Protalix BioTherapeutics, Inc. Indenture Agreements
6 Contracts & Agreements
- Third Supplemental Indenture, dated as of August 24, 2021, by and among Protalix BioTherapeutics, Inc., the guarantors party hereto and The Bank of New York Mellon Trust Company,... (Filed With SEC on August 26, 2021)
- Second Supplemental Indenture, dated as of November 27, 2017, by and among Protalix BioTherapeutics, Inc., the guarantors party hereto and The Bank of New York Mellon Trust... (Filed With SEC on December 1, 2017)
- FIRST SupplementalIndenture between PROTALIXBIOTHERAPEUTICS, INC., as Issuer, ANDEACH OF THE GUARANTORS PARTY HERETO, and TheBank of New York Mellon Trust CoMPANY, N.A., as... (Filed With SEC on July 25, 2017)
- Protalix BioTherapeutics, Inc. (Company) The Bank of New York Mellon Trust Company, N.A.,as Trustee (Trustee) 4.50% Convertible Senior Notes due 2022 INDENTURE Dated as of July... (Filed With SEC on July 25, 2017)
- PROTALIX BIOTHERAPEUTICS, INC. AS ISSUER AND EACH OF THE GUARANTORS PARTY HERETO 7.50% SENIOR SECURED CONVERTIBLE NOTESDUE 2021 INDENTURE DATED AS OF DECEMBER 7, 2016 THE BANK OF... (Filed With SEC on December 7, 2016)
- ProtalixBioTherapeutics, Inc. (Company) The Bankof New York Mellon Trust Company, N.A. (Trustee) 4.50%Convertible Senior Notes due 2018 INDENTURE Datedas of September 18, 2013 (Filed With SEC on September 18, 2013)
